Annelie Brauner

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications

Synthetic antimicrobial peptide LD4-PP protects the host against E. coli-induced cell death.

Synthetic antimicrobial peptide LD4-PP protects the host against E. coli-induced cell death.

Journal: Frontiers in immunology
Published: September 15, 2025

Vaginal chlorhexidine gluconate versus fluconazole for recurrent vulvovaginal candidiasis: A randomized noninferiority trial.

Vaginal chlorhexidine gluconate versus fluconazole for recurrent vulvovaginal candidiasis: A randomized noninferiority trial.

Journal: PloS one
Published: July 04, 2025

Bacteriostatic and Immunomodulatory Effect of Xylocaine in the Context of in Vitro Bladder Epithelial Cell Infection.

Bacteriostatic and Immunomodulatory Effect of Xylocaine in the Context of in Vitro Bladder Epithelial Cell Infection.

Journal: ACS bio & med chem Au
Published: August 01, 2024

Diabetes compromises tight junction protein claudin 14 in the urinary bladder.

Diabetes compromises tight junction protein claudin 14 in the urinary bladder.

Journal: Cell and tissue research
Published: July 05, 2024

High-risk Escherichia coli clones that cause neonatal meningitis and association with recrudescent infection.

High-risk Escherichia coli clones that cause neonatal meningitis and association with recrudescent infection.

Journal: eLife
Published: April 16, 2024

MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection.

MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection.

Journal: Vaccines
Published: April 02, 2024

MV140 mucosal bacterial vaccine improves uropathogenic E. coli clearance in an experimental model of urinary tract infection.

MV140 mucosal bacterial vaccine improves uropathogenic E. coli clearance in an experimental model of urinary tract infection.

Journal: Research square
Published: June 19, 2023

A Synthetic Cyclized Antimicrobial Peptide with Potent Effects against Drug-Resistant Skin Pathogens.

A Synthetic Cyclized Antimicrobial Peptide with Potent Effects against Drug-Resistant Skin Pathogens.

Journal: ACS infectious diseases
Published: May 03, 2023

Epigenetic modifications influence urinary tract infection outcome.

Epigenetic modifications influence urinary tract infection outcome.

Journal: Nature microbiology
Published: April 17, 2023

Inhibition of COX-2 signaling favors E. coli during urinary tract infection.

Inhibition of COX-2 signaling favors E. coli during urinary tract infection.

Journal: Journal of inflammation (London, England)
Published: December 22, 2022

A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens.

A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens.

Journal: Cellular and molecular life sciences : CMLS
Published: April 20, 2022

Antibiotic knowledge, attitudes and reported practice during pregnancy and six months after birth: a follow- up study in Lao PDR.

Antibiotic knowledge, attitudes and reported practice during pregnancy and six months after birth: a follow- up study in Lao PDR.

Journal: BMC pregnancy and childbirth
Published: March 24, 2022
Showing 1-12 of 66

Last Updated: 09/26/2026